1. Home
  2. PHIN vs HAE Comparison

PHIN vs HAE Comparison

Compare PHIN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PHINIA Inc.

PHIN

PHINIA Inc.

HOLD

Current Price

$75.71

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$75.07

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHIN
HAE
Founded
2023
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
PHIN
HAE
Price
$75.71
$75.07
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
$70.00
$84.13
AVG Volume (30 Days)
466.4K
1.0M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
1.66%
N/A
EPS Growth
84.09
N/A
EPS
0.96
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$6.35
N/A
Revenue Next Year
$2.29
$5.23
P/E Ratio
$78.86
$36.62
Revenue Growth
N/A
N/A
52 Week Low
$46.78
$47.32
52 Week High
$86.94
$87.32

Technical Indicators

Market Signals
Indicator
PHIN
HAE
Relative Strength Index (RSI) 41.17 58.67
Support Level $68.81 $72.04
Resistance Level $81.04 $86.72
Average True Range (ATR) 3.00 3.02
MACD -0.78 -0.57
Stochastic Oscillator 14.99 34.04

Price Performance

Historical Comparison
PHIN
HAE

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: